Inventage Lab, Inc. announced a private placement of convertible preferred shares of 579,150 at the price of KRW 91,077 for the gross proceeds of KRW 52,747,244,550 on March 6, 2026. The transaction includes new and returning investors participation of Samsung Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., The Korea Securities Finance Corporation, Korea Securities & Securities Co., Ltd., Shinhan Bank, NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., 2024 IBK Innovation-AJU Good Venture Fund 3.0, Shinhan Time BM Materials, Parts and Equipment New Technology Fund, Oasis Investments ll Master Fund LTD., Flexus Loftyrock Bio New Technology Fund No. 2, STASSETS No.

3 Entrepreneurial Venture Specialist PEF, STASSETS -Flow No. 1 PEF, Mirae Asset Venture Investment Co., Ltd., Mirae Asset AI Frontier Fund, IMM Growth Venture Fund II, LS Securities Co., Ltd., Forged Capital Co., Ltd., Deep Tech Life Science BNH 6 Fund, IBK - Stonebridge Rising Fund II, Stonebridge New Growth 4.0 Investment Fund, Kiwoom-Focus No. 2 New Technology Business Fund, IBKC-Medici Technology Innovation Investment Fund, Woori 2022 Scale Up Fund, Protec Investment Co., Ltd. for convertible preferred shares.

The transaction will happen through third party allocation. The securities are 100% convertible into 579,150 common shares of the company at a conversion price value of KRW 91,077. The conversion billing period starts from March 17, 2027 to March 16, 2031.The transaction has been approved by the board of directors of the company.

The transaction is expected to close on March 16, 2026. All the securities issued under the offering is subject to a lock in period of 1 year from the date of issuance.